Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01534923 · ClinicalTrials.gov registry record
Doctor-Patient Communication About Colorectal Cancer Screening
A clinical trial of Colorectal Cancer Screening, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 76
- Enrollment target
- 2
- Study locations
NCT01534923: Completed study of Colorectal Cancer Screening, sponsored by Memorial Sloan Kettering Cancer Center.
NCT01534923 is a study of Colorectal Cancer Screening that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 76 participants, below the 5,879-participant average among 19 other Colorectal Cancer Screening trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01534923, a study of Colorectal Cancer Screening, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 76 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to learn more about doctor-patient communication about colon cancer screening. This study will also look to see if there are differences in those who get colon cancer screening based on the discussion the doctor had with the patient.
Primary Outcome
screening adherence through self report. Screening adherence will be assessed by contacting the patients and asking them if they received the CRC screening test their doctor ordered at the audio recorded visit.
Conditions Studied
Interventions
- BEHAVIORAL surveys
Study Locations (2)
New York
- Albert Einstein College of Medicine - The Bronx
- Hhc, Gun Hill and Tremont - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2012-02-07 |
| Est. Completion | 2019-12-26 |
What the finished NCT01534923 record still lists
NCT01534923 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 76 participants, a relatively small participant target, below the 5,879-participant average among 19 other Colorectal Cancer Screening trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Colorectal Cancer Screening appearing as the primary indexed condition, and to 1 intervention - of which surveys is the first listed.
NCT01534923 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01534923 about?
NCT01534923 is a clinical study titled "Doctor-Patient Communication About Colorectal Cancer Screening". The purpose of this study is to learn more about doctor-patient communication about colon cancer screening. This study will also look to see if there are differences in those who get colon cancer screening based on the discussion the doctor had with the patient.
What is the current status of trial NCT01534923?
This trial is currently completed. The enrollment target is 76 participants. The study started on 2012-02-07. Estimated completion is 2019-12-26.
What conditions does trial NCT01534923 study?
This clinical trial studies the following conditions: Colorectal Cancer Screening.
What interventions are being tested in trial NCT01534923?
The interventions under investigation include: surveys (BEHAVIORAL).
Who is sponsoring clinical trial NCT01534923?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01534923 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer Screening
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01534923's enrollment target sits among peer trials
76 16th of 19 higher than 4 of 19 other Colorectal Cancer Screening trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colorectal Cancer Screening trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Protect Your Colon™ on CRC Screening
RECRUITING · NA
-
Cleansing Options in Out-Patient Setting to Improve Tolerance (COOP SIT) Trial
RECRUITING · Phase 4
-
Use of a Colorectal Cancer Screening Decision Support Tool in Primary Care
RECRUITING · NA
-
A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
RECRUITING
-
Effectiveness of a Cloud-based Digital Health Navigation Program for Colorectal Cancer Screening
RECRUITING · NA
-
Pilot Study for Colorectal Cancer and Advanced Adenoma Detection With the Mainz Biomed Colorectal Cancer Test
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02615184 · 76 participants · Phase 2
A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old
- NCT02821741 · 76 participants · NA
Effects of External Ear Stimulation on Pain Perception and Mood
- NCT03019757 · 76 participants
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
- NCT03353584 · 76 participants · NA
Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI